Screening & diagnostic pathway for genetic and chromosomal syndromes under 7

A dysmorphic feature, a feeding difficulty, a developmental lag — the first clinician to look closely is often the one who changes a child's trajectory.

In short

For children under 7, the pathway is stepwise: clinical suspicion from history, examination and developmental surveillance, followed by targeted first-tier genetic testing and parallel multidisciplinary developmental assessment. Chromosomal microarray (CMA) is the recommended first-tier test for unexplained global developmental delay, intellectual disability, multiple congenital anomalies or dysmorphism. Crucially, genetic confirmation and habilitation run in parallel — therapy does not wait for a molecular result.

The science and the pathway

Recognise. Combine surveillance at every well-child contact (AAP-aligned schedule) with examination for dysmorphology, growth aberration, organ malformation, hypotonia or regression. Confirmed or suspected hearing/vision deficits warrant prompt sensory work-up.

Test, in tiers. First-tier CMA detects copy-number variants; add karyotype where aneuploidy (e.g. Trisomy 21) or balanced rearrangement is suspected, and Fragile X testing in unexplained delay, especially with a positive family history. Targeted single-gene tests, methylation studies (Prader-Willi/Angelman) or exome sequencing follow phenotype-led hypotheses, ideally via clinical genetics referral.

Assess function alongside. Diagnostic yield never replaces a functional developmental profile across communication, cognition, motor, sensory and self-care — this drives the actual intervention plan and is repeatable for tracking progress.

Refer promptly when red flags co-occur: regression, multiple anomalies, family history, or delay unexplained by environment.

The Pinnacle way

A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care — never from an online form. Our clinician-administered structured assessment profiles current functioning to anchor a habilitation plan that begins while genetic work-up proceeds. Explore the condition pathway and coordinate early intervention without delay.

Trusted sources

AAP developmental surveillance and screening guidance; WHO ICD-11 framework for functioning and diagnosis; consensus recommendations on chromosomal microarray as first-tier testing in developmental delay and congenital anomalies.

Next step — For a child with unexplained delay or dysmorphism, initiate clinical genetics referral and book a parallel developmental assessment at your nearest Pinnacle centre.

This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.